E-ISSN: 2619-9467

Contents    Cover    Publication Date: 18 Nov 2022
Year 2022 - Volume 32 - Issue 4

Open Access

Peer Reviewed

ORIGINAL RESEARCH
810 Viewed891 Downloaded

Gestational Diabetes Screening Refusal in Pregnant Women: A Cross-Sectional Survey Study

Full Text PDF  
JCOG. 2022;32(4):127-34
DOI: 10.5336/jcog.2022-91549
Article Language: EN
Copyright Ⓒ 2020 by Türkiye Klinikleri. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)
ABSTRACT
Objective: Recently, some pregnant women in Türkiye are hesitant to undergo gestational diabetes mellitus (GDM) screening tests and this trend is more common. The objective of the study is to assess the pregnant women's knowledges, decisions, reasons for hesitations about having the GDM screening tests and test rejection rates. Material and Methods: This cross-sectional study included 647 pregnant women who applied for an antenatal outpatient clinic and who had not yet been diagnosed with GDM and a survey was conducted using questionnaire designed by the authors. Results: At the beginning, 287 (44.4%) of the participants declared that they would have glucose challenge test, 169 (26.1%) would not and 191 (29.5%) were undecided. The rejection rate was lower in those who had knowledge about the screening tests. After a short information about the content of tests, 30% of the women who decided not to have the test and 78.3% of those who were undecided at the beginning, decided to have the test (p=0.001). Conclusion: The knowledge level of pregnant women about diabetes screening and diagnosis influences their decision-making. Organizing well-planned trainings for patients and healthcare professionals using public institutions and media may be effective in reducing the burden of diabetes on social health and the economic indicators.
REFERENCES:
  1. McKee C, Bohannon K. Exploring the reasons behind parental refusal of vaccines. J Pediatr Pharmacol Ther. 2016;21(2):104-9. [Crossref]  [PubMed]  [PMC] 
  2. Ohel I, Levy A, Mazor M, Wiznitzer A, Sheiner E. Refusal of treatment in obstetrics-A maternal-fetal conflict. J Matern Fetal Neonatal Med. 2009;22(7):612-5. [Crossref]  [PubMed] 
  3. Agarwal MM, Dhatt GS, Othman Y. Gestational diabetes: differences between the current international diagnostic criteria and implications of switching to IADPSG. J Diabetes Complications. 2015;29(4):544-9. [Crossref]  [PubMed] 
  4. Buckley BS, Harreiter J, Damm P, Corcoy R, Chico A, Simmons D, et al; DALI Core Investigator Group. Gestational diabetes mellitus in Europe: prevalence, current screening practice and barriers to screening. A review. Diabet Med. 2012;29(7):844-54. [Crossref]  [PubMed] 
  5. Mokdad AH, Ford ES, Bowman BA, Dietz WH, Vinicor F, Bales VS, et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA. 2003;289(1):76-9. [Crossref]  [PubMed] 
  6. Lucas MJ. Diabetes complicating pregnancy. Obstet Gynecol Clin North Am. 2001;28(3):513-36. [Crossref]  [PubMed] 
  7. Horvath K, Koch K, Jeitler K, Matyas E, Bender R, Bastian H, et al. Effects of treatment in women with gestational diabetes mellitus: systematic review and meta-analysis. BMJ. 2010;340:c1395. [Crossref]  [PubMed]  [PMC] 
  8. Hanna FW, Peters JR. Screening for gestational diabetes; past, present and future. Diabet Med. 2002;19(5):351-8. [Crossref]  [PubMed] 
  9. Kansu-Celik H, Ozgu-Erdinc AS, Kisa-Karakaya B, Tasci Y, Erkaya S. Fasting and post-prandial plasma glucose screening for gestational diabetes mellitus. East Mediterr Health J. 2019;25(4):282-9. [Crossref]  [PubMed] 
  10. Hocaoglu M, Turgut A, Guzin K, Yardimci OD, Gunay T, Bor ED, et al. Why some pregnant women refuse glucose challenge test? Turkish pregnant women's perspectives for gestational diabetes mellitus screening. North Clin Istanb. 2018;6(1):7-12. [Crossref]  [PubMed]  [PMC] 
  11. Uy AB, Chiu HH, Larrazabal R Jr, Jimeno C. An exploration of knowledge and themes on diabetes during outpatient consultation in a Tertiary Referral Hospital. J ASEAN Fed Endocr Soc. 2021;36(1):31-6. [Crossref]  [PubMed]  [PMC] 
  12. Rai AS, Sletner L, Jenum AK, Øverby NC, Stafne SN, Lekva T, et al. Identifying women with gestational diabetes based on maternal characteristics: an analysis of four Norwegian prospective studies. BMC Pregnancy Childbirth. 2021;21(1):615. [Crossref]  [PubMed]  [PMC] 
  13. Chen LM, Farwell WR, Jha AK. Primary care visit duration and quality: does good care take longer? Arch Intern Med. 2009;169(20):1866-72. [Crossref]  [PubMed] 
  14. Helmersen M, Sørensen M, Lukasse M, Laine HK, Garnweidner-Holme L. Women's experience with receiving advice on diet and Self-Monitoring of blood glucose for gestational diabetes mellitus: a qualitative study. Scand J Prim Health Care. 2021;39(1):44-50. [Crossref]  [PubMed]  [PMC] 
  15. van de Brug A, de Winter MA, Ten Wolde M, Kaasjager K, Nijkeuter M. Deciding on treatment duration for unprovoked venous thromboembolism: what is ımportant to patients? Thromb Haemost. 2022;122(4):600-10. [Crossref]  [PubMed] 
  16. Draffin CR, Alderdice FA, McCance DR, Maresh M, Harper Md Consultant Physician R, et al. Exploring the needs, concerns and knowledge of women diagnosed with gestational diabetes: a qualitative study. Midwifery. 2016;40:141-7. [Crossref]  [PubMed] 
  17. Dickens BM, Cook RJ. Patients' refusal of recommended treatment. Int J Gynaecol Obstet. 2015;131(1):105-8. [Crossref]  [PubMed]